期刊文献+

普罗布考对动脉粥样硬化兔血红素氧合酶1表达的影响 被引量:14

Effect of Probucol on Heme Oxygenase-1 in Rabbits with Atherosclerosis
下载PDF
导出
摘要 目的观察血红素氧合酶1蛋白在兔主动脉粥样硬化病变和肝脏中的表达以及普罗布考对血红素氧合酶1表达的影响。方法16只新西兰大白兔建立动脉粥样硬化模型后,随机加喂普罗布考(n=8,普罗布考组)或淀粉(n=8,淀粉组)6周。观察两组兔以及正常新西兰大白兔(n=8,正常对照组)血脂、体重和血清丙二醛含量。采用免疫组织化学法测定主动脉和肝脏血红素氧合酶1蛋白的表达。结果与淀粉组相比,普罗布考组血红素氧合酶1在主动脉和肝脏内表达增多,动脉粥样斑块减少,血清总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇和丙二醛明显降低。血红素氧合酶1在动脉内膜斑块、动脉平滑肌以及肝脏内的表达水平与血清丙二醛、主动脉斑块面积、内膜厚度、动脉内膜中膜厚度比均呈明显负相关(P均<0.05)。结论普罗布考在降低胆固醇的同时,还可能通过上调血红素氧合酶1发挥抗氧化作用,这可能是其抗动脉粥样硬化的重要途径。 Aim To observe the effect of probucol on the expression of heme oxygenase- 1 { HO- 1 ) protein in athoroselerotic lesions and livers in rabbits. Methods The hypercholestrolemic model was built up by 8 weeks high cholesterol diet. Then 16 New Zealand rabbits were randomly fed with starch ( n = 8, starch group) or probucol (n = 8, probucol group ) for 6 weeks. Those two groups and another 8 New Zealand rabbits (n = 8, control group) were tested for serum lipid, body weight and serum malon dialdehyde (MDA). Expression of HO-1 was detected by immunohistochemistry. Results Probucol treatment increased HO-1 expression in atherosclemtic plaque, aorta smooth muscle cell and liver, decreased atherosclemtic areas, initma thicknesses, and ratio of intimae to media, and down regulated serum total cholesterol (TC), low density lipoprotein cholesterol ( LDLC), high density lipoprotein cholesterol (HDLC) and MDA. Expression of HO-1 protein in atherosclerotic plaque, smooth muscle cell and liver in hypercholesterolemic rabbits with and without probucol treatment was negatively correlated with serum levels of MDA, atherosclerotic areas,imimae thickness,and the ratio of infimae to media ( P 〈 0.05). Conclusions While lowering serum cholesterol, probucol may also exert anti-oxidative actions through upregulation of HO-1 expressions, which might be an important part of its anti-atherogenic properties.
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第6期440-444,共5页 Chinese Journal of Arteriosclerosis
关键词 内科学 普罗布考 血红素氧合酶1 动脉粥样硬化 Probucol Heme Oxygenase-1 A therosclerosis
  • 相关文献

参考文献12

  • 1余艳辉,瞿湘萍,李智,郭兆贵.兔高脂蛋白血症模型建立及动脉粥样斑块形成的方法学[J].中国药理学通报,1998,14(5):473-474. 被引量:29
  • 2赵水平,洪绍彩,邓平,吴智鸿.普罗布考对主动脉粥样斑块形成及血栓调节蛋白的影响[J].中国动脉硬化杂志,2006,14(6):503-507. 被引量:12
  • 3张梅,张运,张园园,高月花.舒降之、普罗布考和开搏通对颈动脉和股动脉内膜中膜厚度的影响[J].中国动脉硬化杂志,2004,12(1):61-64. 被引量:18
  • 4Sawayama Y, Shimizu C, Maeda N, et al. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FASY) [J]. J Am Coll Cardiol, 2002, 39 (4): 610-616.
  • 5Tanous D,Hime N,Stocker R.Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds[J].Redox Rep,2008,13(2):48-59.
  • 6Hong SC,Zhao SP,Wu ZH.Effect of probucol on HDL metabolism and class B type Ⅰ scavenger receptor (SR-BI)expression in the liver of hypercholesterolemic rabbits[J].Int J Cardiol,2007,115(1):29-35.
  • 7Jeon SM, Park YB, Kwon OS, et al. Vitamin E supplementation alters HDL- cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: comparison with probucol [J]. J Biochem Mol Toxicol, 2005, 19 (5): 336-346.
  • 8Deng YM, Wu BJ, Witting PK, et al. Probucol protects against smooth muscle cell proliferation by upregulating heine oxygenas-1 [J]. Circulation, 2004, 110 (13): 1 855-860.
  • 9Chung HT, Pae HO, Cha YN. Role of heine oxygebase-1 in vascular [J]. Curr Pharm Des, 2008, 14 (5): 422-428.
  • 10Orozco LD, Kapturczak MH, Barajas B, et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis [J]. Circ Res, 2007, 100 (12): 1 703-711.

二级参考文献32

  • 1王双 ,杨永宗 ,唐雅玲 ,唐朝克 ,易光辉 ,孙玉慧 ,叶旭 ,许增祥 ,彭旷 ,彭倩 ,万载阳 .化合物48/80对载脂蛋白E基因敲除小鼠主动脉斑块的影响[J].中国动脉硬化杂志,2005,13(3):292-296. 被引量:2
  • 2严鹏科,廖端芳,涂剑,王蓉蓉,唐朝克,万载阳,杨永宗.细胞质膜小凹/小凹蛋白1在实验性动脉粥样硬化小鼠血管壁中的表达变化[J].中国动脉硬化杂志,2005,13(3):301-304. 被引量:1
  • 3Blann AD,Taberner DA.A reliable marker of endothelial cell dysfunction:does it exist[J]? Br J Haematol,1995,90 (2):224-228
  • 4Tagawa T,Urabe Y,Kimura Y,Suzuki S,Ono H,Takeda K.Long-term treatment with probucol improves endothelial function in patients with coronary artery disease[J].Hypertens Res,2004,27 (5):311-318
  • 5Witting PK,Wu BJ,Raftery M,Southwell-keely P,Stocker R.Probucol protects against hypochlorite-induced endothelial dysfunction.Identification of a novel pathway of probucol oxidation to a biologically active intermediate[J].J Biol Chem,2005,280 (16):15 612-618
  • 6Ross R.The pathogenesis of atherosclerosis:a perspective for the 1990s[J].Nature,1993,362 (6423):801-809
  • 7Badimon L,Martinez-Gonzalez J.Endothelium and vascular protection:an update[J].Rev Esp Cardiol,2002,55 (Supl 1):17-26
  • 8van Oostrom AJ,van Wijk J,Cabezas MC.Lipidemia,inflammation and atherosclerosis:novel opportunities in the understanding and treatment of atherosclerosis.Drugs,2004,64 (suppl 2):19-41
  • 9Tardif JC,Cote G,Lesperance J,Bourassa M,Lambert J,Doucet S,et al.Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.Multivitamins and Probucol Study Group[J].N Engl J Med,1997,337 (6):365-372
  • 10Lankin VZ,Tikhaze AK,Konovalova GG,Tutunov VS,Medvedeva NV,Kotkina TI,et al.Intensification of free radical oxidation of low-density lipoproteins in the plasma of patients with ischemic heart disease receiving beta-hydroxy-beta-methylglutaryl-coenzyme a reductase inhibitor cerivastatin and inhibition of low-density lipoprotein peroxidation with antioxidant probucol[J].Bull Exp Biol Med,2002,134 (1):39-42

共引文献54

同被引文献196

引证文献14

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部